Dr. Seema A. Khan, M.D.
Claim this profileNorthwestern University
Studies Breast Cancer
Studies Thyroid Cancer
12 reported clinical trials
13 drugs studied
Area of expertise
1Breast Cancer
BRCA1 positive
Stage II
Stage I
2Thyroid Cancer
Stage II
Stage I
Stage III
Affiliated Hospitals
Clinical Trials Seema A. Khan, M.D. is currently running
Tamoxifen
for Breast Cancer Risk Reduction
This phase II trial evaluates response-guided low-dose tamoxifen for reducing breast density in women who are at higher than average risk for breast cancer. Increasing breast density is a well established risk factor for breast cancer. Tamoxifen is a selective estrogen receptor modulator. It works by blocking the effects of the hormone estrogen in the breast. Tamoxifen has been shown to reduce breast density, even at reduced dosages, and is approved for the prevention of breast cancer.
Recruiting1 award Phase 2
Acolbifene vs. Tamoxifen
for Breast Cancer Prevention
This trial is testing two pills, acolbifene and low dose tamoxifen, to prevent breast cancer in premenopausal women at high risk. These women are chosen because they have a much higher chance of developing breast cancer. The drugs work by blocking estrogen, which can help stop the growth of cancer cells. Acolbifene is being assessed for breast cancer prevention, while tamoxifen has been widely studied and used for reducing breast cancer risk.
Recruiting1 award Phase 216 criteria
More about Seema A. Khan, M.D.
Clinical Trial Related6 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Seema A. Khan, M.D. has experience with
- Tamoxifen
- Afimoxifene
- Endoxifen Hydrochloride
- DCISionRT Test
- Placebo
- Conjugated Estrogens/Bazedoxifene
Breakdown of trials Seema A. Khan, M.D. has run
Breast Cancer
Thyroid Cancer
Vulval Intraepithelial Neoplasia
Ductal Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Seema A. Khan, M.D. specialize in?
Seema A. Khan, M.D. focuses on Breast Cancer and Thyroid Cancer. In particular, much of their work with Breast Cancer has involved BRCA1 positive patients, or patients who are Stage II.
Is Seema A. Khan, M.D. currently recruiting for clinical trials?
Yes, Seema A. Khan, M.D. is currently recruiting for 5 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Seema A. Khan, M.D. has studied deeply?
Yes, Seema A. Khan, M.D. has studied treatments such as Tamoxifen, Afimoxifene, Endoxifen Hydrochloride.
What is the best way to schedule an appointment with Seema A. Khan, M.D.?
Apply for one of the trials that Seema A. Khan, M.D. is conducting.
What is the office address of Seema A. Khan, M.D.?
The office of Seema A. Khan, M.D. is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.